Works matching IS 22974725 AND DT 2016 AND VI 32 AND IP 2
Results: 18
Meetings and Conferences.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 144, doi. 10.1159/000445786
- Publication type:
- Article
CitraFleet® als einzige Natriumpicosulfat-Lösung zur Darmreinigung mit zugelassener «Split-Dose»-Einnahme!
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 142
- Publication type:
- Article
Mit Weitblick den Therapieerfolg anhaltend sichern: Orales Vancomycin zur Behandlung der Clostridium difficile-assoziierten Diarrhoe.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 142
- Publication type:
- Article
Leitlinien-Update veröffentlicht: Paradigmenwechsel in der Helicobacter pylori-Therapie.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 141
- Publication type:
- Article
«Wir glauben, dass dies ein Durchbruch in der Behandlung der PSC sein könnte».
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 141
- Publication type:
- Article
Europäische Zulassungsbehörde prüft Zulassungsantrag für Tenofir Alafenamid (TAF) zur Behandlung der chronischen Hepatitis B.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 141
- Publication type:
- Article
Daclatasvir: Einfache und hocheffektive HCV-Therapie auch bei HIV-Koinfektion.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 140
- By:
- Publication type:
- Article
Hepatitis C-Free Europe Is Possible by 2030.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 138
- By:
- Publication type:
- Article
Incidence of Metachronous Distant Metastasis and ypN Classification Influence Patient Survival in Endosonographically Confirmed uT3 Rectal Cancer after Neoadjuvant Therapy and R0 Resection: A Historical Cohort Analysis.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 131, doi. 10.1159/000442066
- By:
- Publication type:
- Article
Viral Hepatitis and Its Complications: Management of Hepatocellular Carcinoma.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 127, doi. 10.1159/000445306
- Publication type:
- Article
Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 121, doi. 10.1159/000444990
- By:
- Publication type:
- Article
Diagnostics and Treatment of Hepatocellular Carcinoma in 2016: Standards and Developments.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 116, doi. 10.1159/000445730
- By:
- Publication type:
- Article
Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver Cirrhosis.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 110, doi. 10.1159/000445407
- By:
- Publication type:
- Article
Pre- and Post-Transplant Antiviral Therapy (HBV, HCV).
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 105, doi. 10.1159/000445152
- By:
- Publication type:
- Article
Management of HCV-Associated Liver Cirrhosis.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 96, doi. 10.1159/000445330
- By:
- Publication type:
- Article
Management of HBV and HBV/HDV-Associated Liver Cirrhosis.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 86, doi. 10.1159/000445518
- By:
- Publication type:
- Article
Liver Failure due to Acute Viral Hepatitis (A-E).
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 80, doi. 10.1159/000444915
- By:
- Publication type:
- Article
Viral Hepatitis and Its Complications.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 2, p. 78, doi. 10.1159/000445984
- By:
- Publication type:
- Article